The Novartis approval was totally expected. The phase 3 trial results were discussed last year. CB congratulated them on Twitter. Telix will enter this space( hopefully) after the successful completion of the phase 3 trial which has just started recruitment. Novartis are not competing for imaging and tlx are not ready(yet) to compete on therapy. Anyone selling on the Novartis news doesn’t deserve their shares
How low will it go?, page-101
-
- There are more pages in this discussion • 32 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add TLX (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$22.98 |
Change
-0.490(2.09%) |
Mkt cap ! $7.691B | |||
| Open | High | Low | Value | Volume |
| $23.25 | $23.36 | $22.78 | $32.40M | 1.409M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 100 | $22.94 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $22.99 | 421 | 1 |
View Market Depth
| Last trade - 16.10pm 13/11/2024 (20 minute delay) ? |
| TLX (ASX) Chart |